Apoptosis in heart failure represents programmed cell survival, not death, of cardiomyocytes and likelihood of reverse remodeling

Journal of Cardiac Failure

Volumn 8, Issue 6 SUPPL., 2002, Pages

  Haider, Nezam ^a   Narula, Navneet ^a,b   Narula, Jagat ^a,c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c HAHNEMANN UNIVERSITY HOSPITAL   (United States)

Author keywords

Apoptosis interruptus; Nerosis; Remodeling caspases; Zombie myocytes

Indexed keywords

CASPASE 3; CYTOCHROME C; DNA FRAGMENT;

APOPTOSIS; CELL SURVIVAL; CONFERENCE PAPER; DNA DAMAGE; ENZYME INHIBITION; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; PRIORITY JOURNAL; SYSTOLE;

EID: 0036947077     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2002.130034     Document Type: Conference Paper

References (46)

1. American Heart Association: Heart and Stroke Facts. 2002. www.Americanheart.org
2. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldmanmd AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr: ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 2001;104:2996-3007
3. Massie BM, Conway M: Survival of patients with congestive heart failure: Past, present, and future prospects. Circulation 1987;7:IV11-19
4. Kannel WB, Sorlie P, McNamara PM: Prognosis after the initial myocardial infarction: The Framingham study. Am J Cardiol 1979;44:53-59
5. Lichstein E, Hager WD, Gregory JJ, Fleiss JL, Rolnitzky LM, Bigger JT for the Multicenter Diltiazem Postinfarction Research Group: Relation between beta adrenergic blocker use, various correlates of left ventricular dysfunction and the chance of developing congestive heart failure. J Am Coll Cardiol 1990;16:1327-1332
6. Sharp DN, Smith H, Murphy J, Greaves S, Hart H, Gamble G: Early prevention of left ventricular dysfunction following myocardial infarction with angiotensin converting enzyme inhibition. Lancet 1991;337:872-876
7. Konstam MA, Rousseau MF, Kronenberg MW: Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation 1992;86:431-438
8. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-1172
9. Gerdes AM, Capasso JM: Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure. J Mol Cell Cardiol 1995;27:849-856
10. Francis GS, McDonald KM: Left ventricular hypertrophy: An initial response to myocardial injury. Am J Cardiol 1992;69:3G-9G
11. Beltrami CA, Finato N, Rocco M: Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994;89:151-163
12. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Sonnenblick E: The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol 1995;27:291-305
13. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L: Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation 1990;82:1730-1736
14. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J Med 1991;325:293-302
15. Packer M: The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20:248-254
16. Rona G: Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985;17:291-306
17. Tan LB, Jalil JE, Pick R, Janicki JS, Weber KT: Cardiac myocyte necrosis induced by angiotensin II. Circ Res 1991;69:1185-1195
18. Bing OH: Hypothesis: Apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. J Mol Cell Cardiol 1994;26(8):943-948
19. Katz AM: The cardiomyopathy of overload: An unnatural growth response in the hypertrophied heart. Ann Intern Med 1994;121:363-371
20. Kajstura J, Zhang X, Liu Y: The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation 1995;92:2306-2317
21. Pouleur HG, Konstam MA, Udelson JE, Rousseau MF: Changes in ventricular volume, wall thickness and wall stress during progression of left ventricular dysfunction. The SOLVD Investigators. J Am Coll Cardiol 1993;22:43A-48A
22. Francis GS, Carlyle WC: Hypothetical pathways of cardiac myocyte hypertrophy: Response to myocardial injury. Eur Heart J 1993;14(suppl J):49-56
23. Anand IS, Liu D, Chugh SS, Prahash AJ, Gupta S, John R, Popescu F, Chandrashekhar Y: Isolated myocytes contractile function is normal in postinfarct remodeled rat heart with systolic dysfunction. Circulation 1997;96:3974-3984
24. Gaudron P, Eilles C, Kugler I, Ertl G: Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 1993;87(3):755-763
25. Teiger E, Dam TV, Richard L: Apoptosis in pressure overload induced heart hypertrophy in the rat. J Clin Invest 1997;97:2891-2897
26. Li Z, Bing OH, Long X, Robinson KG, Lakatta EG: Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol 1997;272:H2313-H2319
27. Cheng W, Kajstura J, Nitahara JA: Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exper Cell Res 1996;226:316-327
28. Agah R, Kirshenbaum LA, Abdellatiff M, Truong LD, Chakraborty S, Michael LH, Schneider MD: Adenoviral delivery of E2F-1 directs cell cycle reentry and p 53-independent apoptosis in post mitotic adult myocardium in vitro. J Clin Invest 1997;100:2722-2728
29. Narula J, Haider N, Virmani R: Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-1189
30. Olivetti G, Abbi R, Quaini F: Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-1141
31. Kanoh M, Takemura G, Miaao J, Hayakawa Y, Aoyama T, Nishigaki K, Noda T, Fujiwara T, Fukuda K, Mitatoguchi S, Fujiwara H: Significance of myocytes with DNA in situ nick-end labeling (TUNEL) in hearts with dilated cardiomyopathy: Not apoptosis but DNA repair. Circulation 1999;99:2757-2764
32. Liu X, Kim CN, Yang J, Jemmerson R, Wang X: Induction of apoptotic program in cell free extracts: Requirement of dATP and cytochrome-C. Cell 1996;60:147-158
33. Nagata S. Apoptosis by death factor. [Review] Cell 1997;88:355-365
34. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X: Bid, a Bcl interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998;94:481-490
35. Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD, Dal Bello B, Semigran MJ, Bielsa-Masdeu A, Dec GW. Israels S, Ballester M, Virmani R, Saxena S, Kharbanda S: Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A 1999;96:8144-8149
36. Narula N, Arbustini E, Haider N, Raghunath PN, Goorman J, Goorman R, Tomaszewski JE, Narula J: Although apoptotic, myofibrillarlytic myocytes demonstrate survival instincts. United States and Canadian Academy of Pathology, Chicago; February 2002. Mod Pathol 2002;38A
37. Narula J, Southern JF, Dec GW, Palacios IF, Fallon JT, Strauss HW, Khaw BA, Yasuda T: Antimyosin uptake and myofibrillarlysis in dilated cardiomyopathy. J Nucl Cardiol 1995;2:470-477
38. Communal C, Narula J, Solaro J, Hajjar RJ: Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci U S A 2002 (in press).
39. Haider N, Kharbanda SK, Chandrashekhar Y, Srinivasula SM, Fitzpatrick JM, Anand IS, Alnemri ES, Narula J: Caspase-3 mediated cleavage of troponin-C at evolutionarily-conserved calcium binding site: Relevance of apoptosis in heart failure. Circulation 1999;100:283
40. Weneker D, Nguyen KT, Khine CC, Chandra M, Carantziotis S, Ng K, Factor SM, Shirani J, Kitsis RN: Myocyte apoptosis is sufficient to cause dilated cardiomyopathy. Circulation 1999;100(suppl I):17. Abstract.
41. Narula J, Arbustini E, Chandrashekhar Y, Schwaiger M: Apoptosis and the systolic dysfunction in congestive heart failure. Story of apoptosis interruptus and zombie myocytes. Cardiol Clin 2001;19:113-126
42. Reed JC, Paternostro G: Postmitochondrial regulation of apoptosis during heart failure. Proc Natl Acad Sci U S A 1999;996:7614-7616
43. Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P: Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J Exp Med 1997;185:1481-1486
44. Eguchi Y, Shimizu S, Tsujimoto Y: Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 1997;57:1835-1840
45. Milting H, Bartling B, Schumann H: Altered levels of NRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilated cardiomyopathy - First results of the Halle Assist Induced Recovery Study (HAIR). Cardiovasc Surg 1999;47:48-50
46. Bartling B, Milting H, Schumann H: Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostatis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. Circulation 1999;100:216-223